Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Gyros Announces Changes to its Management Team

Published: Monday, October 24, 2011
Last Updated: Sunday, October 23, 2011
Bookmark and Share
Dr. Jon-Sverre Schanche becomes Chief Technology Officer and Vice President Technical Affairs.

Gyros AB has announced the appointment of Dr. Jon-Sverre Schanche as Chief Technology Officer and Vice President Technical Affairs.

Dr. Schanche’s appointment comes as Nils Kristensen, COO and VP Technical Operations, and Stephan Hoffmann, VP Business Development, leave the company.

Dr. Schanche has almost thirty years of industrial R&D and management experience. In his new role he will hold responsibility for business and product development as well as production and manufacturing.

Most recently, Dr. Schanche was Vice President R&D at DAKO Denmark A/S where he established a system development organization for in vitro diagnostic products.

Before this, he held executive roles within the drug discovery and biotechnology supply industry, including Vice President of R&D in Personal Chemistry AB and Biotage AB and several senior management positions in Amersham Pharmacia Biotech (now GE Healthcare), including General Manager for the Norwegian R&D site.

Erik Walldén, CEO at Gyros, commented, “We are extremely pleased to make this appointment. Dr. Schanche brings a wealth of experience that will further enhance Gyros’ ability to develop its nanoscale immunoassay platform for time-critical workflows in the biopharmaceutical industry”.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Gyros Wins SwedenBIO Award 2011
Company selected to receive the award based on the international success of the Gyros immunoassay platform.
Friday, May 27, 2011
Gyros platform enters leading US Clinical Research Organization
CEDRA Corporation, a division of Worldwide Clinical Trials, invests in Gyrolab workstation
Tuesday, March 16, 2010
Gyros Platform Ramps Up Immunoassay Capacity at ICON Development Solutions
CRO purchases third Gyrolab workstation to develop and run immunoassays.
Friday, March 12, 2010
Gyros and SCRUM Sign Distribution Agreement for the Japanese Market
SCRUM will market, sell and fully support the Gyros product range, within the Japanese life-science market industries.
Wednesday, February 17, 2010
Gyros has Completed the Separate Sales of two Microfluidic System Platforms
Gyros platform for protein quantification is purchased by AstraZeneca and Cambridge Antibody Technology.
Wednesday, August 09, 2006
Gyros Awarded Frost & Sullivan Technology of the Year Award
The award recognizes the company’s technology development and overall technical excellence.
Wednesday, November 16, 2005
Gyros AB licenses technology to Cellectricon AB

Tuesday, April 15, 2003
Gyros expands with German office

Monday, December 02, 2002
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Gut Model HuMiX Works Like the Real Thing
Developed by scientists at the Luxembourg Centre for Systems Biology, the “Human Microbial Cross-talk” model is representative of the actual conditions and processes that occur within our intestines.
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!